英国科学家进行血液测试,精确预测IBD病人的肠癌风险。 UK scientists create a blood test that accurately predicts bowel cancer risk in IBD patients.

英国研究人员开发了血液测试,精确预测5年内患炎性肠道疾病(IBD)的高危人群的肠道癌风险,其准确度超过90%。 UK researchers have developed a blood test with over 90% accuracy in predicting bowel cancer risk in high-risk individuals with inflammatory bowel disease (IBD) within five years. 测试分析癌症前细胞的DNA变化,帮助医生确定哪些IBD病人风险最高,有可能使低风险病人免于正常结肠检查或外科手术。 The test analyzes DNA changes in pre-cancerous cells, helping doctors determine which IBD patients are at highest risk, potentially sparing lower-risk patients from regular colonoscopies or surgery. 该研究涉及122名IBD病人,其中约半数在五年内患了肠癌。 The study involved 122 IBD patients, about half of whom developed bowel cancer within five years.